Side-by-side comparison of AI visibility scores, market position, and capabilities
Santa Clara semiconductor manufacturer (NASDAQ: INTC) $53.1B FY2024 revenue; $18.8B net loss, Gelsinger resignation Dec 2024, Intel 18A foundry bet, losing CPU/GPU share to AMD and NVIDIA.
Intel Corporation is a Santa Clara, California-based semiconductor company — publicly traded on the NASDAQ (NASDAQ: INTC) as an S&P 500 Information Technology component — designing and manufacturing microprocessors, chipsets, graphics processors, FPGAs, Ethernet controllers, and AI accelerators for personal computers, data center servers, network infrastructure, and embedded applications through approximately 108,000 employees (reduced from 120,000 through 2024 workforce restructuring). Intel faces its most significant competitive and strategic challenge in its 55-year history: in fiscal year 2024, Intel reported revenues of $53.1 billion (-2% year-over-year) with a net loss of approximately $18.8 billion — reflecting $16.6 billion in goodwill and asset impairment charges related to Intel Foundry's strategic reassessment, the most severe annual loss in Intel's history. CEO Pat Gelsinger resigned in December 2024 (effectively forced out by the Intel board after 4 years of leading the IDM 2.0 / Intel Foundry turnaround strategy) — with David Zinsner and Michelle Johnston Holthaus serving as interim co-CEOs while the board searched for a permanent successor. Intel's IDM 2.0 strategy (building Intel Foundry as an external contract semiconductor manufacturer competing with TSMC and Samsung Foundry) consumed $20+ billion in capital expenditure annually to construct the Ohio One and Arizona Fab 52/62 fabs while Intel's own products (Core Ultra processors, Gaudi AI accelerator) lost market share to AMD Ryzen CPUs and NVIDIA's GPU dominance — leaving Intel financially strained from capital deployment while failing to reverse the competitive momentum losses in its product businesses.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.